38.27
price down icon2.15%   -0.84
after-market Dopo l'orario di chiusura: 38.29 0.02 +0.05%
loading

Perché le azioni Crispr Therapeutics Ag (CRSP) sono in ribasso?

Abbiamo notato un calo di 5.39% nelle azioni di Crispr Therapeutics Ag (CRSP) durante la sessione di negoziazione di 2025-04-10. Sebbene ciò possa essere attribuito alla normale volatilità o a vari fattori interni ed esterni, tieni presente che stiamo monitorando attivamente la situazione e forniremo aggiornamenti tempestivi il prima possibile!
2023-11-13:

CRISPR Therapeutics AG Stock (CRSP) dropped by 2.16% from $53.16 to $52.01 in the trading on Monday November 13, 2023. The reason why CRSP stock down today is due to the recent lower price target by the analysts.

  • On Monday, Morgan Stanley analyst Terence Flynn maintained CRISPR Therapeutics with an Underweight and lowered the price target from $43 to $42.
  • Last Tuesday, RBC Capital analyst Luca Issi maintains CRISPR Therapeutics with a Sector Perform and lowered the price target from $55 to $50.
  • Needham analyst Gil Blum maintained CRISPR Therapeutics with a Buy and lowered the price target from $88 to $85.
2023-10-02:

CRISPR Therapeutics AG Stock (CRSP) dropped by 6.57% from $45.39 to 42.41 in the trading on Monday October 2, 2023. The reason why stock CRSP is down is due to upcoming FDA decisions for exa-cel. The company is awaiting FDA decisions on its exa-cel gene therapy for sickle cell disease and beta-thalassemia. These decisions are anticipated in the near future, and a few investors might be selling their CRSP shares before the decisions are made, which cause CRSP stock down.

$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
Capitalizzazione:     |  Volume (24 ore):